tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRQR Stock Latest News

ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
The FlyProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
26d ago
PRQR
ProQR Submits CTA for Phase 1 Study of AX-0810
PremiumCompany Announcements
ProQR Submits CTA for Phase 1 Study of AX-0810
1M ago
6K
PRQR
ProQR Shareholders Approve Key Resolutions at Annual Meeting
PremiumCompany Announcements
ProQR Shareholders Approve Key Resolutions at Annual Meeting
2M ago
6K
PRQR
ProQR Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
ProQR Therapeutics Reports Q1 2025 Financial Results
2M ago
PRQR
ProQR Therapeutics price target lowered to $9 from $15 at Oppenheimer
PremiumThe Fly
ProQR Therapeutics price target lowered to $9 from $15 at Oppenheimer
3M ago
PRQR
ProQR’s Innovative RNA Editing Platform and Promising AX-0810 Program Drive Buy Rating
PremiumRatingsProQR’s Innovative RNA Editing Platform and Promising AX-0810 Program Drive Buy Rating
3M ago
PRQR
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
Premium
Company Announcements
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
3M ago
6K
PRQR
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
Premium
The Fly
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
3M ago
PRQR
PRQR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PRQR Upcoming Earnings Report: What to Expect?
3M ago
PRQR
ProQR Schedules Annual Shareholders Meeting for June 3, 2025
PremiumCompany Announcements
ProQR Schedules Annual Shareholders Meeting for June 3, 2025
3M ago
6K
PRQR
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
3M ago
PRQR
ProQR Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe Fly
ProQR Therapeutics initiated with an Outperform at Evercore ISI
3M ago
PRQR
ProQR Announces New CFO and CMO to Drive Growth
PremiumCompany AnnouncementsProQR Announces New CFO and CMO to Drive Growth
4M ago
6K
PRQR
ProQR Therapeutics appoints Hom as CFO, Lopez as CMO
Premium
The Fly
ProQR Therapeutics appoints Hom as CFO, Lopez as CMO
4M ago
PRQR
ProQR Therapeutics Advances RNA Editing Pipeline
Premium
Company Announcements
ProQR Therapeutics Advances RNA Editing Pipeline
4M ago
PRQR
ProQR’s Axiomer Technology and AX-0810: A Promising Buy Rating with Increased Price Target
PremiumRatings
ProQR’s Axiomer Technology and AX-0810: A Promising Buy Rating with Increased Price Target
5M ago
PRQR
ProQR Therapeutics price target raised to $12 from $10 at H.C. Wainwright
PremiumThe Fly
ProQR Therapeutics price target raised to $12 from $10 at H.C. Wainwright
5M ago
PRQR
ProQR Therapeutics files to sell 3.52M ordinary shares for holders
PremiumThe Fly
ProQR Therapeutics files to sell 3.52M ordinary shares for holders
5M ago
PRQR
ProQR Therapeutics Reports 2024 Results and Pipeline Progress
PremiumCompany Announcements
ProQR Therapeutics Reports 2024 Results and Pipeline Progress
5M ago
6K
PRQR
ProQR Therapeutics reports FY24 EPS (EUR 0.32) vs (EUR 0.35) last year
PremiumThe FlyProQR Therapeutics reports FY24 EPS (EUR 0.32) vs (EUR 0.35) last year
5M ago
PRQR
ProQR’s Undervalued Potential: Buy Rating on Promising Pipeline and Market Opportunity
Premium
Ratings
ProQR’s Undervalued Potential: Buy Rating on Promising Pipeline and Market Opportunity
5M ago
PRQR
ProQR Therapeutics upgraded to Buy from Neutral at Citi
Premium
The Fly
ProQR Therapeutics upgraded to Buy from Neutral at Citi
5M ago
PRQR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >